These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11590980)

  • 1. Sexual dysfunction and HAART.
    TreatmentUpdate; 2001 Aug; 13(4):5-7. PubMed ID: 11590980
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors.
    Moreno-Pérez O; Escoín C; Serna-Candel C; Picó A; Alfayate R; Merino E; Reus S; Boix V; Sanchez-Paya J; Portilla J
    AIDS; 2010 Jan; 24(2):255-64. PubMed ID: 19915446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual dysfunction and HAART--is there a connection?
    Dunable D
    Surviv News (Atlanta Ga); 2002 Nov; ():9. PubMed ID: 12506864
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition. Study finds vitamin B12 levels low in some HAART users.
    TreatmentUpdate; 2003 Oct; 15(6):6-7. PubMed ID: 17216864
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction in the highly active antiretroviral therapy era.
    Collazos J
    AIDS Rev; 2007; 9(4):237-45. PubMed ID: 18219367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity. Study finds that HAART is OK for some people co-infected with hepatitis B and C virus.
    TreatmentUpdate; 2000 Feb; 12(1):6-7. PubMed ID: 12125630
    [No Abstract]   [Full Text] [Related]  

  • 14. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications & side effects. HAART and bones-mixed messages.
    TreatmentUpdate; 2007; 19(4):3-5. PubMed ID: 17969257
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy.
    Chu JH; Gange SJ; Anastos K; Minkoff H; Cejtin H; Bacon M; Levine A; Greenblatt RM
    Am J Epidemiol; 2005 May; 161(9):881-90. PubMed ID: 15840621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV agents. Starting HAART and its effect on survival.
    TreatmentUpdate; 2002 Jan; 14(1):3-5. PubMed ID: 12141237
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV agents. The benefit of HAART in older people.
    TreatmentUpdate; 2001; 12(8):2-3. PubMed ID: 12132437
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of HAART in early HIV infection.
    TreatmentUpdate; 2001; 12(12):14. PubMed ID: 11570080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.